Estimating inverse probability weights using super learner when weight‐model specification is unknown in a marginal structural Cox model context
暂无分享,去创建一个
[1] P. Gustafson,et al. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study , 2014, European journal of neurology.
[2] E. Moodie,et al. Flexible Marginal Structural Models for Estimating the Cumulative Effect of a Time-Dependent Treatment on the Hazard: Reassessing the Cardiovascular Risks of Didanosine Treatment in the Swiss HIV Cohort Study , 2014 .
[3] P. Gustafson,et al. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. , 2012, JAMA.
[4] Til Stürmer,et al. The role of the c‐statistic in variable selection for propensity score models , 2011, Pharmacoepidemiology and drug safety.
[5] Jessica A. Myers,et al. Myers et al. Respond to “Understanding Bias Amplification” , 2011 .
[6] J. Myers,et al. Effects of adjusting for instrumental variables on bias and precision of effect estimates. , 2011, American journal of epidemiology.
[7] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[8] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .
[9] X. Basagaña,et al. Differences Between Marginal Structural Models and Conventional Models in Their Exposure Effect Estimates: A Systematic Review , 2011, Epidemiology.
[10] J. Pearl. Invited commentary: understanding bias amplification. , 2011, American journal of epidemiology.
[11] Brian K. Lee,et al. Weight Trimming and Propensity Score Weighting , 2011, PloS one.
[12] P. Gustafson,et al. Practice of Epidemiology Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort , 2014 .
[13] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[14] D. Lio,et al. Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives , 2015, BioMed research international.
[15] M. Chandra,et al. A Marginal Structural Modeling Approach with Super Learning for a Study on Oral Bisphosphonate Therapy and Atrial Fibrillation , 2013 .
[16] Michal Abrahamowicz,et al. Comparison of Approaches to Weight Truncation for Marginal Structural Cox Models , 2013 .
[17] S. Schneeweiss,et al. Practice of Epidemiology Implications of M Bias in Epidemiologic Studies: a Simulation Study , 2022 .
[18] P. Gustafson,et al. Beta‐interferon exposure and onset of secondary progressive multiple sclerosis , 2015, European journal of neurology.
[19] Cheng Ju,et al. Using Super Learner Prediction Modeling to Improve High-dimensional Propensity Score Estimation , 2018, Epidemiology.
[20] Performance of the marginal structural models under various scenarios of incomplete marker's values: A simulation study , 2015, Biometrical journal. Biometrische Zeitschrift.
[21] Stephen R Cole,et al. An information criterion for marginal structural models , 2013, Statistics in medicine.
[22] M. J. van der Laan,et al. Practice of Epidemiology Improving Propensity Score Estimators ’ Robustness to Model Misspecification Using Super Learner , 2015 .
[23] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[24] The Impact of Sparse Follow-up on Marginal Structural Models for Time-to-Event Data. , 2015, American journal of epidemiology.
[25] Romain Neugebauer,et al. High‐dimensional propensity score algorithm in comparative effectiveness research with time‐varying interventions , 2015, Statistics in medicine.
[26] P. Gustafson,et al. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies , 2018, Statistical methods in medical research.
[27] Helen Tremlett,et al. On the application of statistical learning approaches to construct inverse probability weights in marginal structural Cox models: Hedging against weight-model misspecification , 2017, Commun. Stat. Simul. Comput..
[28] J. Avorn,et al. Variable selection for propensity score models. , 2006, American journal of epidemiology.
[29] M. Hernán. Invited commentary: hypothetical interventions to define causal effects--afterthought or prerequisite? , 2005, American journal of epidemiology.
[30] R. Ali,et al. On computing standard errors for marginal structural Cox models , 2014, Lifetime data analysis.
[31] Jessica G. Young,et al. Simulation from a known Cox MSM using standard parametric models for the g‐formula , 2014, Statistics in medicine.
[32] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[33] Til Stürmer,et al. Balancing Automated Procedures for Confounding Control with Background Knowledge , 2014 .
[34] Patrick J O'Connor,et al. Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling. , 2013, Journal of clinical epidemiology.
[35] P. Gustafson,et al. Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies. , 2016, American journal of epidemiology.
[36] Karsten M. Borgwardt,et al. ccSVM: correcting Support Vector Machines for confounding factors in biological data classification , 2011, Bioinform..
[37] M. E. Karim. Causal inference approaches for dealing with time-dependent confounding in longitudinal studies, with applications to multiple sclerosis research , 2015 .
[38] J Elith,et al. A working guide to boosted regression trees. , 2008, The Journal of animal ecology.
[39] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[40] Michal Abrahamowicz,et al. Accuracy of Conventional and Marginal Structural Cox Model Estimators: A Simulation Study , 2010, The international journal of biostatistics.
[41] Jessica G. Young,et al. Relation between three classes of structural models for the effect of a time-varying exposure on survival , 2010, Lifetime data analysis.
[42] K. Lapane,et al. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review , 2014, Pharmacoepidemiology and drug safety.
[43] David A. Binder,et al. Fitting Cox's proportional hazards models from survey data , 1992 .
[44] W G Havercroft,et al. Simulating from marginal structural models with time‐dependent confounding , 2012, Statistics in medicine.
[45] Sunduz Keles,et al. Statistical Applications in Genetics and Molecular Biology Supervised Detection of Conserved Motifs in DNA Sequences with Cosmo , 2011 .
[46] M. J. van der Laan,et al. Analysis of longitudinal marginal structural models. , 2004, Biostatistics.
[47] M. G. Pittau,et al. A weakly informative default prior distribution for logistic and other regression models , 2008, 0901.4011.
[48] Peter C. Austin,et al. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis , 2016, Statistics in medicine.
[49] S. Cole,et al. A simulation study of finite‐sample properties of marginal structural Cox proportional hazards models , 2012, Statistics in medicine.
[50] J. Robins,et al. Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments , 2001 .
[51] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[52] S. Cole,et al. Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death. , 2010, American journal of epidemiology.
[53] P. Gustafson,et al. Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment , 2015, BioMed research international.
[54] Peter C Austin,et al. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study , 2007, Statistics in medicine.
[55] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[56] Romain Neugebauer,et al. An application of model-fitting procedures for marginal structural models. , 2005, American journal of epidemiology.
[57] Geneviève Lefebvre,et al. Impact of mis‐specification of the treatment model on estimates from a marginal structural model , 2008, Statistics in medicine.
[58] James M Robins,et al. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. , 2005, American journal of epidemiology.
[59] Susan Gruber,et al. Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets , 2015, Statistics in medicine.
[60] S. Rose. Mortality risk score prediction in an elderly population using machine learning. , 2013, American journal of epidemiology.
[61] James M. Robins,et al. Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .
[62] David A Stephens,et al. A marginal structural model for multiple‐outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co‐infection Cohort , 2014, Statistics in medicine.